Details for New Drug Application (NDA): 088484
✉ Email this page to a colleague
NDA 088484 describes MEDROXYPROGESTERONE ACETATE, which is a drug marketed by Amneal, Amphastar Pharms Inc, Cipla, Eugia Pharma, Hikma, Hong Kong, Sandoz, Sun Pharm, Teva Pharms Usa, Xiromed, Barr, Duramed Pharms Barr, and Upsher Smith Labs, and is included in sixteen NDAs. It is available from twenty-one suppliers. Additional details are available on the MEDROXYPROGESTERONE ACETATE profile page.
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 088484
| Tradename: | MEDROXYPROGESTERONE ACETATE |
| Applicant: | Upsher Smith Labs |
| Ingredient: | medroxyprogesterone acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088484
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Jul 26, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
